| Havenwood-heritage Heights | |
| 33 Christian Avenue, Concord, New Hampshire 03301 | |
| (603) 224-5363 | |
| Name | Havenwood-heritage Heights |
|---|---|
| Location | 33 Christian Avenue, Concord, New Hampshire |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 70 |
| Occupancy Rate | 81.86% |
| Medicare ID (CCN) | 305016 |
| Legal Business Name | United Church Of Christ Retirement Community Inc |
| Ownership Type | Non Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
In recent years, research has suggested that carbon monoxide, the highly toxic gas emitted from auto exhausts and faulty heating systems, can be used to treat certain inflammatory medical conditions. Now a study led by a research team at Beth Israel Deaconess Medical Center (BIDMC) shows for the first time that carbon monoxide may also have a role to play in treating cancer.
The PHOENIX trial is a European, placebo-controlled, Phase III study treating catecholamine-resistant patients in distributive shock with the Nitric Oxide (NO) scavenger Pyridoxalated Haemoglobin Polyoxyethylene Conjugate (PHP). The study was launched by Curacyte AG in Austria, Belgium, Germany, Spain, The Netherlands and in the United Kingdom in 2009.
CML is caused by the breakage and swapping of chromosomes 9 and 22, which results in a shortened chromosome called the Philadelphia chromosome. Cells with the abnormal chromosome make a protein that encourages aberrant growth and division. Patients with CML can be treated with a drug called imatinib or interferon alfa.
To mark Day of the African Child on Tuesday, the U.N. Millennium Campaign is calling on African governments, civil society organizations and the private sector to address child and maternal mortality and other targets related to the U.N. Millennium Development Goals (MDGs), InDepthNews reports (Mwanda, InDepthNews, 6/16), while Save the Children released a new briefing paper, indicating that more than 1,500 babies born in sub-Saharan Africa die daily, "mostly from preventable or treatable causes," (Save the Children release, 6/16).
It's one of the first questions asked by many newly-diagnosed cancer patients-"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 21.05 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.36 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 67.92 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.64 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.16 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.19 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.7 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.45 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.92 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.52 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 30.62 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 7.02 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0.94 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 91.06 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.43 | 82.93 |
News Archive
In recent years, research has suggested that carbon monoxide, the highly toxic gas emitted from auto exhausts and faulty heating systems, can be used to treat certain inflammatory medical conditions. Now a study led by a research team at Beth Israel Deaconess Medical Center (BIDMC) shows for the first time that carbon monoxide may also have a role to play in treating cancer.
The PHOENIX trial is a European, placebo-controlled, Phase III study treating catecholamine-resistant patients in distributive shock with the Nitric Oxide (NO) scavenger Pyridoxalated Haemoglobin Polyoxyethylene Conjugate (PHP). The study was launched by Curacyte AG in Austria, Belgium, Germany, Spain, The Netherlands and in the United Kingdom in 2009.
CML is caused by the breakage and swapping of chromosomes 9 and 22, which results in a shortened chromosome called the Philadelphia chromosome. Cells with the abnormal chromosome make a protein that encourages aberrant growth and division. Patients with CML can be treated with a drug called imatinib or interferon alfa.
To mark Day of the African Child on Tuesday, the U.N. Millennium Campaign is calling on African governments, civil society organizations and the private sector to address child and maternal mortality and other targets related to the U.N. Millennium Development Goals (MDGs), InDepthNews reports (Mwanda, InDepthNews, 6/16), while Save the Children released a new briefing paper, indicating that more than 1,500 babies born in sub-Saharan Africa die daily, "mostly from preventable or treatable causes," (Save the Children release, 6/16).
It's one of the first questions asked by many newly-diagnosed cancer patients-"What are my chances of beating this?" Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options.
› Verified 5 days ago
Havenwood-heritage Heights Location: 33 Christian Avenue, Concord, New Hampshire 03301 Phone: (603) 224-5363 | |
Pleasant View Center, Genesis Healthcare Location: 239 Pleasant Street, Concord, New Hampshire 03301 Phone: (603) 224-6561 | |
Harris Hill Center, Genesis Healthcare Location: 20 Maitland Street, Concord, New Hampshire 03301 Phone: (603) 224-1319 |